The Survival Advantage of Females at Premenopausal Age Is Race Dependent in Colorectal Cancer

被引:0
|
作者
Sheng, Hui [1 ]
Wei, Xiaoli [2 ]
Chen, Qunxi [3 ]
Huang, Kewei [4 ]
Han, Runkun [4 ]
Liu, Yijun [4 ]
Liu, Wen [4 ]
Mao, Minjie [4 ]
机构
[1] Sun Yat sen Univ, Dept Expt Res, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China
[2] Sun Yat sen Univ, Dept Med Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China
[3] Sun Yat sen Univ, Dept Pathol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China
[4] Sun Yat sen Univ, Dept Clin Lab, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou 510060, Peoples R China
关键词
ESTROGEN-RECEPTOR-BETA; BREAST-CANCER; COLON-CANCER; GENDER-DIFFERENCES; LUNG-CANCER; ER-BETA; SEX; RISK; ETHNICITY; THERAPY;
D O I
10.1155/2020/7434783
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background. A female prognostic advantage in younger individuals has been demonstrated in various cancers. Several large-scale analyses based on different racial backgrounds have reported inconsistent results in colorectal cancer. The aim of the present study was to evaluate the prognostic value of sex and age in patients with colorectal cancer of different ethnic groups. Methods. We identified 71,812 eligible patients from the Surveillance, Epidemiology and End Results database. According to age at diagnosis, the patients were categorized into premenopausal age (<= 45 yrs), menopausal age (46-54 yrs), and postmenopausal age (>= 55 yrs) subgroups for further analysis. Results. Multivariate analysis identified the female survival advantage to be significant in the premenopausal age subgroup (P=0.002, HR (95% CI): 0.73 (0.60-0.89)), diminished in the menopausal age subgroup (P=0.09), and absent in the postmenopausal age subgroup (P=0.96). Furthermore, the female survival advantage at premenopausal age was significant only in white patients (P=0.001, HR (95% CI): 0.68 (0.54-0.87)) and not in either American Indian/Alaska Native or Asian or Pacific Islander patients. There was a trend of better survival of females in black patients (P=0.07). Conclusions. Sex was a major prognostic factor in colorectal cancer patients, especially premenopausal women, and the difference was also associated with race.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Race, age and advanced stage colorectal cancer survival
    Wallace, Kristin
    Gore, Elena
    Sterba, Katherine R.
    Hill, Elizabeth G.
    Oppenheimer, Stephanie
    Palmieri, Vincent
    Lewin, David N.
    Ford, Marvella E.
    Alberg, Anthony J.
    Thomas, Melanie B.
    [J]. CANCER RESEARCH, 2012, 72
  • [2] Race and colorectal cancer survival
    Robbins, Anthony S.
    [J]. COLORECTAL CANCER, 2012, 1 (02) : 103 - 106
  • [3] Interaction Between Age and Race Alters Predicted Survival in Colorectal Cancer
    Uma R. Phatak
    Lillian S. Kao
    Stefanos G. Millas
    Rebecca L. Wiatrek
    Tien C. Ko
    Curtis J. Wray
    [J]. Annals of Surgical Oncology, 2013, 20 : 3363 - 3369
  • [4] Interaction Between Age and Race Alters Predicted Survival in Colorectal Cancer
    Phatak, Uma R.
    Kao, Lillian S.
    Millas, Stefanos G.
    Wiatrek, Rebecca L.
    Ko, Tien C.
    Wray, Curtis J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (11) : 3363 - 3369
  • [5] Colorectal cancer, survival advantage, and hereditary nonpolyposis colorectal carcinoma
    Lynch, HT
    Smyrk, T
    [J]. GASTROENTEROLOGY, 1996, 110 (03) : 943 - 947
  • [6] Colorectal Cancer Survival Advantage through Maintenance Treatment
    Krome, Susanne
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (15) : 1121 - 1121
  • [7] Disparities in survival improvement for metastatic colorectal cancer by race/ethnicity and age in the United States
    Sineshaw, Helmneh M.
    Robbins, Anthony S.
    Jemal, Ahmedin
    [J]. CANCER CAUSES & CONTROL, 2014, 25 (04) : 419 - 423
  • [8] Disparities in survival improvement for metastatic colorectal cancer by race/ethnicity and age in the United States
    Helmneh M. Sineshaw
    Anthony S. Robbins
    Ahmedin Jemal
    [J]. Cancer Causes & Control, 2014, 25 : 419 - 423
  • [9] Overall Survival Advantage through Ribociclib for premenopausal Women with metastatic Breast Cancer
    Ruckhaeberle, E.
    [J]. ONKOLOGE, 2020, 26 (07): : 656 - 657
  • [10] Lack of survival advantage in critically ill, reproductive-age females with sepsis
    Barie, PS
    Hydo, LJ
    Eachempati, SR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (12) : A61 - A61